VThunter
a database for single-cell screening of virus target cells in animal kingdom
Alpaca

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Artiodactyla; Tylopoda; Camelidae; Vicugna,

Latin Name: Vicugna pacos

Tested tissues: Frontal, Liver, Lung, PBMC,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0001 2021.04 10X Genomics Frontal Normal 3583 Link
Vthunter_0002 2021.04 10X Genomics Liver Normal 10408 Link
Vthunter_0003 2021.04 10X Genomics Lung Normal 1430 Link
Vthunter_0059 2021.04 iDrop PBMC Normal 793 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Human mastadenovirus B
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
Frontal-Microglia : 30.25% ;
PBMC-Neutrophil : 26.27% ;
Human mastadenovirus D
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Classical swine fever virus
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Human betaherpesvirus 6
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
Measles morbillivirus
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
Human betaherpesvirus 6A
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
Rabies lyssavirus
Frontal-Inhibitory neurons : 100.00% ;
Frontal-Excitatory neurons : 99.92% ;
Frontal-Oligodendrocyte progenitor cells : 99.56% ;
Frontal-Astrocytes : 99.32% ;
Frontal-Oligodendrocytes : 98.88% ;
Liver-Hepatic stellate cells : 23.44% ;
Bovine viral diarrhea virus 1
Frontal-Endothelial cells : 100.00% ;
PBMC-B cells : 81.90% ;
PBMC-T cells : 76.21% ;
PBMC-Neutrophil : 72.16% ;
Frontal-Inhibitory neurons : 46.15% ;
Hepacivirus C
Frontal-Endothelial cells : 100.00% ;
Frontal-Astrocytes : 80.84% ;
Frontal-Inhibitory neurons : 80.77% ;
Frontal-Excitatory neurons : 74.49% ;
PBMC-B cells : 67.62% ;
Frontal-Endothelial cells : 93.33% ;
Liver-Hepatocytes : 40.54% ;
Lung-ATII : 21.32% ;
Lung-ATI : 19.05% ;
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 53.42% ;
Frontal-Inhibitory neurons : 29.49% ;
Liver-Hepatocytes : 25.02% ;
Frontal-Oligodendrocyte progenitor cells : 21.33% ;
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Frontal-Endothelial cells : 80.00% ;
Liver-Hepatocytes : 70.79% ;
Frontal-Oligodendrocyte progenitor cells : 44.44% ;
Frontal-Astrocytes : 37.29% ;
Frontal-Inhibitory neurons : 28.21% ;
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 36.42% ;
Frontal-Excitatory neurons : 31.34% ;
Frontal-Astrocytes : 23.26% ;
Frontal-Inhibitory neurons : 20.51% ;
Frontal-Endothelial cells : 40.00% ;
Liver-Hepatocytes : 29.54% ;
Vesicular stomatitis virus
Frontal-Excitatory neurons : 97.28% ;
Frontal-Inhibitory neurons : 87.18% ;
Frontal-Endothelial cells : 80.00% ;
Frontal-Microglia : 70.59% ;
Frontal-Astrocytes : 55.87% ;
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 36.42% ;
Frontal-Excitatory neurons : 31.34% ;
Frontal-Astrocytes : 23.26% ;
Frontal-Inhibitory neurons : 20.51% ;
Influenza A virus
Frontal-Excitatory neurons : 97.28% ;
Frontal-Inhibitory neurons : 87.18% ;
Frontal-Endothelial cells : 80.00% ;
Frontal-Microglia : 70.59% ;
Frontal-Astrocytes : 55.87% ;
Frontal-Excitatory neurons : 82.81% ;
Frontal-Inhibitory neurons : 55.13% ;
Frontal-Endothelial cells : 20.00% ;
Frontal-Endothelial cells : 80.00% ;
Frontal-Excitatory neurons : 50.00% ;
PBMC-Neutrophil : 36.08% ;
Frontal-Endothelial cells : 80.00% ;
Liver-Hepatocytes : 70.79% ;
Frontal-Oligodendrocyte progenitor cells : 44.44% ;
Frontal-Astrocytes : 37.29% ;
Frontal-Inhibitory neurons : 28.21% ;
Adeno-associated virus - 2
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Frontal-Inhibitory neurons : 70.51% ;
Frontal-Excitatory neurons : 70.22% ;
Frontal-Endothelial cells : 53.33% ;
Liver-Hepatocytes : 50.75% ;
Lung-ATII : 42.65% ;
PBMC-Neutrophil : 27.45% ;
Frontal-Endothelial cells : 20.00% ;
Echovirus E8
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Lung-Endothelial cells : 33.99% ;
Porcine endogenous retrovirus A
Frontal-Endothelial cells : 93.33% ;
Frontal-Inhibitory neurons : 47.44% ;
Frontal-Excitatory neurons : 45.72% ;
Liver-Hepatocytes : 21.36% ;
Feline immunodeficiency virus
PBMC-Neutrophil : 93.33% ;
PBMC-T cells : 83.14% ;
PBMC-B cells : 81.90% ;
Frontal-Endothelial cells : 20.00% ;
Human gammaherpesvirus 4
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Frontal-Excitatory neurons : 21.00% ;
Human metapneumovirus
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
PBMC-Neutrophil : 27.45% ;
Frontal-Endothelial cells : 20.00% ;
Human rotavirus strain WA
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 27.75% ;
Lung-ATII : 21.32% ;
Lung-Endothelial cells : 33.99% ;
Human parvovirus B19
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
PBMC-Neutrophil : 27.45% ;
Frontal-Endothelial cells : 20.00% ;
Mammalian orthoreovirus
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Frontal-Excitatory neurons : 91.60% ;
Frontal-Endothelial cells : 46.67% ;
Frontal-Inhibitory neurons : 44.87% ;
Frontal-Astrocytes : 18.70% ;
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 27.75% ;
Lung-ATII : 21.32% ;
Human immunodeficiency virus 2
PBMC-Neutrophil : 93.33% ;
PBMC-T cells : 83.14% ;
PBMC-B cells : 81.90% ;
Frontal-Endothelial cells : 20.00% ;
Equid alphaherpesvirus 1
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Liver-Immune cells : 24.54% ;
PBMC-Neutrophil : 20.78% ;
Liver-Kupffer cells : 19.03% ;
Simian rotavirus A strain RRV
Frontal-Endothelial cells : 93.33% ;
Frontal-Inhibitory neurons : 92.31% ;
Frontal-Excitatory neurons : 87.01% ;
Frontal-Astrocytes : 70.92% ;
PBMC-Neutrophil : 68.63% ;
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 27.75% ;
Lung-ATII : 21.32% ;
Lung-Endothelial cells : 33.99% ;
Liver-Kupffer cells : 18.28% ;
Echovirus E1
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Lung-Endothelial cells : 33.99% ;
Human immunodeficiency virus 1
PBMC-Neutrophil : 93.33% ;
PBMC-T cells : 83.14% ;
PBMC-B cells : 81.90% ;
Frontal-Endothelial cells : 20.00% ;
Human betaherpesvirus 5
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Frontal-Endothelial cells : 80.00% ;
Liver-Hepatocytes : 70.79% ;
Frontal-Oligodendrocyte progenitor cells : 44.44% ;
Frontal-Astrocytes : 37.29% ;
Frontal-Inhibitory neurons : 28.21% ;
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Liver-Kupffer cells : 18.28% ;
Foot-and-mouth disease virus
Frontal-Endothelial cells : 93.33% ;
Frontal-Excitatory neurons : 53.19% ;
Frontal-Inhibitory neurons : 50.00% ;
PBMC-Neutrophil : 30.98% ;
PBMC-B cells : 28.57% ;
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Frontal-Oligodendrocyte progenitor cells : 55.11% ;
Frontal-Excitatory neurons : 45.72% ;
Frontal-Astrocytes : 40.02% ;
Frontal-Oligodendrocytes : 35.50% ;
Frontal-Microglia : 24.37% ;
Lung-ATII : 50.74% ;
Lung-Epithelial : 34.04% ;
Lung-ATI : 28.57% ;
PBMC-Neutrophil : 27.45% ;
Frontal-Endothelial cells : 20.00% ;
Liver-Kupffer cells : 18.28% ;
Adeno-associated virus 9
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Venezuelan equine encephalitis virus
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Adeno-associated virus - 3
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Dengue virus
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Liver-Hepatocytes : 29.54% ;
Frontal-Excitatory neurons : 29.16% ;
Frontal-Inhibitory neurons : 25.64% ;
PBMC-Neutrophil : 23.92% ;
Adeno-associated virus - 8
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
Sindbis virus
PBMC-Neutrophil : 92.94% ;
PBMC-T cells : 90.53% ;
PBMC-B cells : 90.48% ;
Frontal-Endothelial cells : 46.67% ;
SARS coronavirus
Liver-Liver sinusoidal endothelial cells : 90.25% ;
Liver-Hepatocytes : 39.88% ;
Liver-Immune cells : 39.26% ;
Liver-Hepatic stellate cells : 37.67% ;
Liver-Kupffer cells : 36.57% ;
Liver-Hepatocytes : 31.07% ;
Lassa mammarenavirus
Liver-Liver sinusoidal endothelial cells : 90.25% ;
Liver-Hepatocytes : 39.88% ;
Liver-Immune cells : 39.26% ;
Liver-Hepatic stellate cells : 37.67% ;
Liver-Kupffer cells : 36.57% ;
Frontal-Endothelial cells : 80.00% ;
Frontal-Excitatory neurons : 70.30% ;
Frontal-Inhibitory neurons : 61.54% ;
PBMC-Neutrophil : 44.31% ;
Frontal-Microglia : 40.34% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Excitatory neurons : 53.34% ;
Frontal-Inhibitory neurons : 52.56% ;
Frontal-Astrocytes : 39.11% ;
Lung-Fibroblasts : 30.60% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Frontal-Excitatory neurons : 29.16% ;
Frontal-Inhibitory neurons : 25.64% ;
Japanese encephalitis virus
Liver-Liver sinusoidal endothelial cells : 90.25% ;
Liver-Hepatocytes : 39.88% ;
Liver-Immune cells : 39.26% ;
Liver-Hepatic stellate cells : 37.67% ;
Liver-Kupffer cells : 36.57% ;
Ebola virus
Liver-Liver sinusoidal endothelial cells : 90.25% ;
Liver-Hepatocytes : 39.88% ;
Liver-Immune cells : 39.26% ;
Liver-Hepatic stellate cells : 37.67% ;
Liver-Kupffer cells : 36.57% ;
Frontal-Astrocytes : 87.46% ;
Frontal-Microglia : 52.94% ;
Frontal-Oligodendrocyte progenitor cells : 47.56% ;
Frontal-Endothelial cells : 40.00% ;
Liver-Kupffer cells : 35.45% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Frontal-Excitatory neurons : 41.14% ;
Frontal-Oligodendrocytes : 36.83% ;
Frontal-Astrocytes : 36.26% ;
PBMC-Neutrophil : 34.90% ;
Frontal-Endothelial cells : 33.33% ;
Frontal-Excitatory neurons : 29.16% ;
Frontal-Inhibitory neurons : 25.64% ;
Lymphocytic choriomeningitis mammarenavirus
Liver-Liver sinusoidal endothelial cells : 90.25% ;
Liver-Hepatocytes : 39.88% ;
Liver-Immune cells : 39.26% ;
Liver-Hepatic stellate cells : 37.67% ;
Liver-Kupffer cells : 36.57% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Excitatory neurons : 53.34% ;
Frontal-Inhibitory neurons : 52.56% ;
Frontal-Astrocytes : 39.11% ;
Lung-Fibroblasts : 30.60% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Marburg marburgvirus
Frontal-Astrocytes : 87.46% ;
Frontal-Microglia : 52.94% ;
Frontal-Oligodendrocyte progenitor cells : 47.56% ;
Frontal-Endothelial cells : 40.00% ;
Liver-Kupffer cells : 35.45% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Frontal-Excitatory neurons : 29.16% ;
Frontal-Inhibitory neurons : 25.64% ;
Guanarito mammarenavirus
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Canine parvovirus
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Machupo mammarenavirus
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Feline panleukopenia virus
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Argentinian mammarenavirus
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Mouse mammary tumor virus
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 82.58% ;
Frontal-Inhibitory neurons : 78.21% ;
PBMC-Neutrophil : 40.00% ;
Liver-Hepatic stellate cells : 31.30% ;
Severe acute respiratory syndrome coronavirus 2
Frontal-Endothelial cells : 86.67% ;
Frontal-Excitatory neurons : 53.42% ;
Frontal-Inhibitory neurons : 29.49% ;
Liver-Hepatocytes : 25.02% ;
Frontal-Oligodendrocyte progenitor cells : 21.33% ;
Liver-Liver sinusoidal endothelial cells : 73.43% ;
Frontal-Endothelial cells : 60.00% ;
Lung-ATII : 42.65% ;
Liver-Hepatic stellate cells : 37.53% ;
Frontal-Microglia : 36.13% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Liver-Hepatocytes : 31.07% ;
Human mastadenovirus A
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Human mastadenovirus E
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Coxsackievirus B5
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Coxsackievirus B3
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Human mastadenovirus F
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Coxsackievirus B6
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Coxsackievirus B4
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Human mastadenovirus C
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Frontal-Endothelial cells : 66.67% ;
Frontal-Microglia : 52.10% ;
Liver-Hepatocytes : 29.88% ;
Frontal-Astrocytes : 28.96% ;
Frontal-Oligodendrocytes : 25.53% ;
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Coxsackievirus B2
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Coxsackievirus B1
Frontal-Excitatory neurons : 84.99% ;
Frontal-Inhibitory neurons : 74.36% ;
Liver-Cholangiocytes : 25.41% ;
Liver-Hepatocytes : 24.78% ;
Lung-ATI : 19.05% ;
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Lung-ATII : 50.74% ;
Lung-Epithelial : 34.04% ;
Lung-ATI : 28.57% ;
Hepatitis delta virus
Liver-Hepatocytes : 84.75% ;
Liver-Immune cells : 31.90% ;
Liver-Hepatic stellate cells : 31.03% ;
Liver-Kupffer cells : 24.63% ;
Liver-Liver sinusoidal endothelial cells : 24.07% ;
Rubella virus
Frontal-Oligodendrocytes : 83.11% ;
Frontal-Microglia : 25.21% ;
Frontal-Excitatory neurons : 18.58% ;
Enterovirus B
Frontal-Endothelial cells : 80.00% ;
Liver-Hepatocytes : 27.08% ;
Frontal-Oligodendrocytes : 26.45% ;
Liver-Cholangiocytes : 24.19% ;
Frontal-Microglia : 23.53% ;
Human papillomavirus type 16
Frontal-Endothelial cells : 80.00% ;
Liver-Liver sinusoidal endothelial cells : 29.56% ;
Frontal-Inhibitory neurons : 28.21% ;
Lung-Endothelial cells : 27.30% ;
Frontal-Astrocytes : 24.06% ;
Frontal-Endothelial cells : 73.33% ;
Frontal-Excitatory neurons : 23.25% ;
Middle East respiratory syndrome-related coronavirus
Liver-Hepatocytes : 78.93% ;
Lung-Endothelial cells : 33.75% ;
Lung-Epithelial : 28.72% ;
Liver-Immune cells : 26.99% ;
Gibbon ape leukemia virus
Frontal-Astrocytes : 77.65% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Oligodendrocytes : 45.98% ;
Frontal-Excitatory neurons : 43.00% ;
Liver-Hepatocytes : 40.09% ;
PBMC-T cells : 57.97% ;
Frontal-Excitatory neurons : 50.70% ;
PBMC-Neutrophil : 50.20% ;
PBMC-B cells : 46.67% ;
Frontal-Inhibitory neurons : 34.62% ;
Feline leukemia virus strain B/lambda-B1
Frontal-Astrocytes : 77.65% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Oligodendrocytes : 45.98% ;
Frontal-Excitatory neurons : 43.00% ;
Liver-Hepatocytes : 40.09% ;
PBMC-T cells : 57.97% ;
Frontal-Excitatory neurons : 50.70% ;
PBMC-Neutrophil : 50.20% ;
PBMC-B cells : 46.67% ;
Frontal-Inhibitory neurons : 34.62% ;
Amphotropic murine leukemia virus
Frontal-Astrocytes : 77.65% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Oligodendrocytes : 45.98% ;
Frontal-Excitatory neurons : 43.00% ;
Liver-Hepatocytes : 40.09% ;
Xenotropic murine leukemia virus
Frontal-Endothelial cells : 73.33% ;
Frontal-Excitatory neurons : 38.26% ;
Frontal-Inhibitory neurons : 29.49% ;
Frontal-Astrocytes : 27.59% ;
Polytropic murine leukemia virus
Frontal-Endothelial cells : 73.33% ;
Frontal-Excitatory neurons : 38.26% ;
Frontal-Inhibitory neurons : 29.49% ;
Frontal-Astrocytes : 27.59% ;
Porcine reproductive and respiratory syndrome virus
Frontal-Endothelial cells : 73.33% ;
Frontal-Excitatory neurons : 23.25% ;
Frontal-Microglia : 33.61% ;
Ecotropic murine leukemia virus
Frontal-Endothelial cells : 73.33% ;
Coxsackievirus A16
Frontal-Excitatory neurons : 71.54% ;
Frontal-Inhibitory neurons : 56.41% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Astrocytes : 34.32% ;
Frontal-Oligodendrocytes : 27.67% ;
Enterovirus A71
Frontal-Excitatory neurons : 71.54% ;
Frontal-Inhibitory neurons : 56.41% ;
Frontal-Endothelial cells : 53.33% ;
Frontal-Astrocytes : 34.32% ;
Frontal-Oligodendrocytes : 27.67% ;
Frontal-Microglia : 20.17% ;
Rhinovirus B14
PBMC-Neutrophil : 67.45% ;
PBMC-B cells : 24.76% ;
Liver-Liver sinusoidal endothelial cells : 24.68% ;
Coxsackievirus A21
PBMC-Neutrophil : 67.45% ;
PBMC-B cells : 24.76% ;
Liver-Liver sinusoidal endothelial cells : 24.68% ;
Suid alphaherpesvirus 1
Frontal-Endothelial cells : 66.67% ;
Frontal-Inhibitory neurons : 28.21% ;
PBMC-Neutrophil : 19.61% ;
Frontal-Excitatory neurons : 18.27% ;
Frontal-Excitatory neurons : 37.79% ;
Frontal-Inhibitory neurons : 20.51% ;
Frontal-Oligodendrocyte progenitor cells : 18.22% ;
Human alphaherpesvirus 2
Frontal-Endothelial cells : 66.67% ;
Frontal-Inhibitory neurons : 28.21% ;
PBMC-Neutrophil : 19.61% ;
Frontal-Excitatory neurons : 18.27% ;
Frontal-Excitatory neurons : 37.79% ;
Frontal-Inhibitory neurons : 20.51% ;
Frontal-Oligodendrocyte progenitor cells : 18.22% ;
Human alphaherpesvirus 1
Frontal-Endothelial cells : 66.67% ;
Frontal-Inhibitory neurons : 28.21% ;
PBMC-Neutrophil : 19.61% ;
Frontal-Excitatory neurons : 18.27% ;
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Frontal-Oligodendrocyte progenitor cells : 55.11% ;
Frontal-Excitatory neurons : 45.72% ;
Frontal-Astrocytes : 40.02% ;
Frontal-Oligodendrocytes : 35.50% ;
Frontal-Microglia : 24.37% ;
Lung-ATII : 50.74% ;
Lung-Epithelial : 34.04% ;
Lung-ATI : 28.57% ;
Frontal-Excitatory neurons : 37.79% ;
Frontal-Inhibitory neurons : 20.51% ;
Frontal-Oligodendrocyte progenitor cells : 18.22% ;
Varicella Zoster Virus
Frontal-Excitatory neurons : 62.44% ;
Frontal-Inhibitory neurons : 48.72% ;
Frontal-Endothelial cells : 46.67% ;
Frontal-Astrocytes : 19.16% ;
Liver-Hepatocytes : 18.94% ;
Human alphaherpesvirus 3
Frontal-Excitatory neurons : 62.44% ;
Frontal-Inhibitory neurons : 48.72% ;
Frontal-Endothelial cells : 46.67% ;
Frontal-Astrocytes : 19.16% ;
Liver-Hepatocytes : 18.94% ;
West Nile virus
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Liver-Kupffer cells : 18.28% ;
Coxsackievirus A9
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Lung-ATII : 50.74% ;
Lung-Epithelial : 34.04% ;
Lung-ATI : 28.57% ;
Liver-Kupffer cells : 18.28% ;
Human parechovirus 1
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Liver-Kupffer cells : 18.28% ;
Human gammaherpesvirus 8
Frontal-Oligodendrocyte progenitor cells : 62.22% ;
Frontal-Endothelial cells : 60.00% ;
Frontal-Astrocytes : 56.67% ;
Frontal-Oligodendrocytes : 43.95% ;
Frontal-Excitatory neurons : 35.77% ;
Liver-Kupffer cells : 18.28% ;
Andes orthohantavirus
Frontal-Excitatory neurons : 61.66% ;
Frontal-Inhibitory neurons : 57.69% ;
Frontal-Endothelial cells : 40.00% ;
Sin Nombre orthohantavirus
Frontal-Excitatory neurons : 61.66% ;
Frontal-Inhibitory neurons : 57.69% ;
Frontal-Endothelial cells : 40.00% ;
Feline calicivirus
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 27.75% ;
Lung-ATII : 21.32% ;
Latino mammarenavirus
Frontal-Endothelial cells : 60.00% ;
Frontal-Excitatory neurons : 53.34% ;
Frontal-Inhibitory neurons : 52.56% ;
Frontal-Astrocytes : 39.11% ;
Lung-Fibroblasts : 30.60% ;
Oliveros mammarenavirus
Frontal-Endothelial cells : 60.00% ;
Frontal-Excitatory neurons : 53.34% ;
Frontal-Inhibitory neurons : 52.56% ;
Frontal-Astrocytes : 39.11% ;
Lung-Fibroblasts : 30.60% ;
Human rhinovirus A2
Frontal-Endothelial cells : 60.00% ;
Liver-Hepatocytes : 36.42% ;
Frontal-Excitatory neurons : 31.34% ;
Frontal-Astrocytes : 23.26% ;
Frontal-Inhibitory neurons : 20.51% ;
Respiratory syncytial virus
Frontal-Microglia : 57.98% ;
Simian sarcoma-associated virus
PBMC-T cells : 57.97% ;
Frontal-Excitatory neurons : 50.70% ;
PBMC-Neutrophil : 50.20% ;
PBMC-B cells : 46.67% ;
Frontal-Inhibitory neurons : 34.62% ;
Feline leukemia virus strain C/FA27
Frontal-Excitatory neurons : 56.30% ;
Frontal-Inhibitory neurons : 53.85% ;
Frontal-Endothelial cells : 20.00% ;
Mayaro virus
Frontal-Excitatory neurons : 53.50% ;
Frontal-Inhibitory neurons : 37.18% ;
Frontal-Endothelial cells : 26.67% ;
Frontal-Astrocytes : 18.47% ;
Onyong-nyong virus
Frontal-Excitatory neurons : 53.50% ;
Frontal-Inhibitory neurons : 37.18% ;
Frontal-Endothelial cells : 26.67% ;
Frontal-Astrocytes : 18.47% ;
Ross River virus
Frontal-Excitatory neurons : 53.50% ;
Frontal-Inhibitory neurons : 37.18% ;
Frontal-Endothelial cells : 26.67% ;
Frontal-Astrocytes : 18.47% ;
Chikungunya virus
Frontal-Excitatory neurons : 53.50% ;
Frontal-Inhibitory neurons : 37.18% ;
Frontal-Endothelial cells : 26.67% ;
Frontal-Astrocytes : 18.47% ;
Murine hepatitis virus
Frontal-Endothelial cells : 53.33% ;
Liver-Liver sinusoidal endothelial cells : 27.42% ;
Zika virus
Frontal-Endothelial cells : 53.33% ;
Frontal-Microglia : 26.89% ;
Frontal-Astrocytes : 19.50% ;
Hendra henipavirus
Frontal-Inhibitory neurons : 48.72% ;
Frontal-Excitatory neurons : 41.99% ;
Lung-Endothelial cells : 28.78% ;
Frontal-Endothelial cells : 20.00% ;
Liver-Liver sinusoidal endothelial cells : 19.01% ;
Nipah henipavirus
Frontal-Inhibitory neurons : 48.72% ;
Frontal-Excitatory neurons : 41.99% ;
Lung-Endothelial cells : 28.78% ;
Frontal-Endothelial cells : 20.00% ;
Liver-Liver sinusoidal endothelial cells : 19.01% ;
Human coronavirus 229E
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Infectious bronchitis virus
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Porcine epidemic diarrhea virus
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Canine coronavirus
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Feline coronavirus
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Transmissible gastroenteritis virus
Lung-Epithelial : 41.49% ;
Frontal-Endothelial cells : 20.00% ;
Rhinovirus C
Lung-Ciliated cells : 37.99% ;
Bovine alphaherpesvirus 1
Frontal-Excitatory neurons : 37.79% ;
Frontal-Inhibitory neurons : 20.51% ;
Frontal-Oligodendrocyte progenitor cells : 18.22% ;
Bovine leukemia virus
PBMC-B cells : 36.19% ;
PBMC-Neutrophil : 31.37% ;
PBMC-T cells : 29.10% ;
Frontal-Inhibitory neurons : 21.79% ;
Frontal-Excitatory neurons : 21.00% ;
Feline endogenous virus RD114
PBMC-Neutrophil : 32.16% ;
Lung-Epithelial : 26.60% ;
PBMC-T cells : 22.17% ;
Simian type D retrovirus -Tsukuba
PBMC-Neutrophil : 32.16% ;
Lung-Epithelial : 26.60% ;
PBMC-T cells : 22.17% ;
Baboon endogenous virus strain M7
PBMC-Neutrophil : 32.16% ;
Lung-Epithelial : 26.60% ;
PBMC-T cells : 22.17% ;
Hepatitis E virus
Lung-ATI : 31.43% ;
Frontal-Excitatory neurons : 31.10% ;
Frontal-Inhibitory neurons : 20.51% ;
Human coronavirus NL63
Liver-Hepatocytes : 31.07% ;
Encephalomyocarditis virus
Liver-Hepatocytes : 29.81% ;
Hepatovirus A
Frontal-Excitatory neurons : 29.16% ;
Frontal-Inhibitory neurons : 25.64% ;
Coxsackievirus A10
Frontal-Astrocytes : 22.58% ;
Hantaan orthohantavirus
Liver-Kupffer cells : 18.28% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China